Australia, April 24 -- Belenos Biosciences Inc., owns the trademark (2519342) for 'BELENOS' till Dec. 19, 2034.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceuticals for the treatment of immune and inflammatory disease; pharmaceutical products for immunotherapy, the treatment of inflammatory diseases, and the treatment infectious diseases.], 35 [New product commercialization services.] and 42 [Drug discovery services: pharmaceutical research and development; provision of medical research and scientific research services and information in the field of pharmaceuticals, immune and inflammatory diseases, and clinical trials; medical research in the field of antibody-based therapies; medical research services in the fields of im...